Literature DB >> 19763788

IL-33 synergizes with IgE-dependent and IgE-independent agents to promote mast cell and basophil activation.

Matthew R Silver1, Alexander Margulis, Nancy Wood, Samuel J Goldman, Marion Kasaian, Divya Chaudhary.   

Abstract

OBJECTIVE: Mast cell and basophil activation contributes to inflammation, bronchoconstriction, and airway hyperresponsiveness in asthma. Because IL-33 expression is inflammation inducible, we investigated IL-33-mediated effects in concert with both IgE-mediated and IgE-independent stimulation.
METHODS: Because the HMC-1 mast cell line can be activated by GPCR and RTK signaling, we studied the effects of IL-33 on these pathways. The IL-33- and SCF-stimulated HMC-1 cells were co-cultured with human lung fibroblasts and airway smooth muscle cells in a collagen gel contraction assay. IL-33 effects on IgE-mediated activation were studied in primary mast cells and basophils. RESULT: IL-33 synergized with adenosine, C5a, SCF, and NGF receptor activation. IL-33-stimulated and SCF-stimulated HMC-1 cells demonstrated enhanced collagen gel contraction when cultured with fibroblasts or smooth muscle cells. IL-33 also synergized with IgE receptor activation of primary human mast cells and basophils.
CONCLUSION: IL-33 amplifies inflammation in both IgE-independent and IgE-dependent responses.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19763788     DOI: 10.1007/s00011-009-0088-5

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  69 in total

1.  IL-4 production by allergen-stimulated primary cultures: identification of basophils as the major IL-4-producing cell type.

Authors:  M T Kasaian; M J Clay; M P Happ; R D Garman; S Hirani; M Luqman
Journal:  Int Immunol       Date:  1996-08       Impact factor: 4.823

2.  IL-13 blockade reduces lung inflammation after Ascaris suum challenge in cynomolgus monkeys.

Authors:  Andrea Bree; Franklin J Schlerman; Michael Wadanoli; Lioudmila Tchistiakova; Kimberly Marquette; Xiang-Yang Tan; Bruce A Jacobson; Angela Widom; Timothy A Cook; Nancy Wood; Suresh Vunnum; Rustem Krykbaev; Xin Xu; Debra D Donaldson; Samuel J Goldman; Joseph Sypek; Marion T Kasaian
Journal:  J Allergy Clin Immunol       Date:  2007-03-26       Impact factor: 10.793

3.  Cross-talk between G(s)- and G(q)-coupled pathways in regulation of interleukin-4 by A(2B) adenosine receptors in human mast cells.

Authors:  Sergey Ryzhov; Anna E Goldstein; Italo Biaggioni; Igor Feoktistov
Journal:  Mol Pharmacol       Date:  2006-05-17       Impact factor: 4.436

4.  Chemokine production by G protein-coupled receptor activation in a human mast cell line: roles of extracellular signal-regulated kinase and NFAT.

Authors:  H Ali; J Ahamed; C Hernandez-Munain; J L Baron; M S Krangel; D D Patel
Journal:  J Immunol       Date:  2000-12-15       Impact factor: 5.422

5.  The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33.

Authors:  Gaby Palmer; Brian P Lipsky; Molly D Smithgall; David Meininger; Sophia Siu; Dominique Talabot-Ayer; Cem Gabay; Dirk E Smith
Journal:  Cytokine       Date:  2008-05-02       Impact factor: 3.861

6.  IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells.

Authors:  Shafaqat Ali; Michael Huber; Christian Kollewe; Stephan C Bischoff; Werner Falk; Michael U Martin
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-14       Impact factor: 11.205

7.  C5a stimulates production of plasminogen activator inhibitor-1 in human mast cells and basophils.

Authors:  Johann Wojta; Christoph Kaun; Gerlinde Zorn; Minoo Ghannadan; Alexander W Hauswirth; Wolfgang R Sperr; Gerhard Fritsch; Dieter Printz; Bernd R Binder; Georg Schatzl; Joerg Zwirner; Gerald Maurer; Kurt Huber; Peter Valent
Journal:  Blood       Date:  2002-07-15       Impact factor: 22.113

Review 8.  IL-1, IL-18, and IL-33 families of cytokines.

Authors:  William P Arend; Gaby Palmer; Cem Gabay
Journal:  Immunol Rev       Date:  2008-06       Impact factor: 12.988

9.  An IL-1 cytokine member, IL-33, induces human basophil activation via its ST2 receptor.

Authors:  Maho Suzukawa; Motoyasu Iikura; Rikiya Koketsu; Hiroyuki Nagase; Chise Tamura; Akiko Komiya; Susumu Nakae; Kouji Matsushima; Ken Ohta; Kazuhiko Yamamoto; Masao Yamaguchi
Journal:  J Immunol       Date:  2008-11-01       Impact factor: 5.422

10.  Investigations into the role of ST2 in acute asthma in children.

Authors:  M Ali; G Zhang; W R Thomas; C J McLean; J A Bizzintino; I A Laing; A C Martin; J Goldblatt; P N Le Souëf; C M Hayden
Journal:  Tissue Antigens       Date:  2009-03
View more
  61 in total

1.  Regulatory T cells and regulation of allergic airway disease.

Authors:  Helen Martin; Christian Taube
Journal:  Am J Clin Exp Immunol       Date:  2012-11-15

Review 2.  IL-33 family members and asthma - bridging innate and adaptive immune responses.

Authors:  Clare M Lloyd
Journal:  Curr Opin Immunol       Date:  2010-11-09       Impact factor: 7.486

3.  TGF-β1 Suppresses IL-33-Induced Mast Cell Function.

Authors:  Victor S Ndaw; Daniel Abebayehu; Andrew J Spence; Patrick A Paez; E Motunrayo Kolawole; Marcela T Taruselli; Heather L Caslin; Alena P Chumanevich; Anuya Paranjape; Bianca Baker; Brian O Barnstein; Tamara T Haque; Kasalina N Kiwanuka; Carole A Oskeritzian; John J Ryan
Journal:  J Immunol       Date:  2017-06-21       Impact factor: 5.422

4.  Involvement of the Negative Feedback of IL-33 Signaling in the Anti-Inflammatory Effect of Electro-acupuncture on Allergic Contact Dermatitis via Targeting MicroRNA-155 in Mast Cells.

Authors:  Zhigang Wang; Tao Yi; Man Long; Fengmin Ding; Lichen Ouyang; Zebin Chen
Journal:  Inflammation       Date:  2018-06       Impact factor: 4.092

Review 5.  Recent advances in our understanding of mast cell activation - or should it be mast cell mediator disorders?

Authors:  Theoharis C Theoharides; Irene Tsilioni; Huali Ren
Journal:  Expert Rev Clin Immunol       Date:  2019-04-22       Impact factor: 4.473

6.  Substance P and IL-33 administered together stimulate a marked secretion of IL-1β from human mast cells, inhibited by methoxyluteolin.

Authors:  Alexandra Taracanova; Irene Tsilioni; Pio Conti; Errol R Norwitz; Susan E Leeman; Theoharis C Theoharides
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-19       Impact factor: 11.205

7.  Identification of an IFN-γ/mast cell axis in a mouse model of chronic asthma.

Authors:  Mang Yu; Michael R Eckart; Alexander A Morgan; Kaori Mukai; Atul J Butte; Mindy Tsai; Stephen J Galli
Journal:  J Clin Invest       Date:  2011-08       Impact factor: 14.808

Review 8.  Emerging role of interleukin-33 in autoimmune diseases.

Authors:  Cheng Pei; Mark Barbour; Karen J Fairlie-Clarke; Debbie Allan; Rong Mu; Hui-Rong Jiang
Journal:  Immunology       Date:  2014-01       Impact factor: 7.397

9.  IL-33 induces a hyporesponsive phenotype in human and mouse mast cells.

Authors:  Mi-Yeon Jung; Daniel Smrž; Avanti Desai; Geethani Bandara; Tomonobu Ito; Shoko Iwaki; Jeong-Han Kang; Marcus V Andrade; Susana C Hilderbrand; Jared M Brown; Michael A Beaven; Dean D Metcalfe; Alasdair M Gilfillan
Journal:  J Immunol       Date:  2012-12-17       Impact factor: 5.422

10.  Activated mast cells synthesize and release soluble ST2-a decoy receptor for IL-33.

Authors:  Geethani Bandara; Michael A Beaven; Ana Olivera; Alasdair M Gilfillan; Dean D Metcalfe
Journal:  Eur J Immunol       Date:  2015-09-09       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.